Literature DB >> 15273840

Magnetic resonance imaging of cavernous sinus invasion by pituitary adenoma diagnostic criteria and surgical findings.

Joaquim O Vieira1, Arthur Cukiert, Bernardo Liberman.   

Abstract

This study used MRI to define preoperative imaging criteria for cavernous sinus invasion (CSI) by pituitary adenoma (PA). MR images of 103 patients with PA submitted to surgery (48 with CSI) were retrospectively reviewed. The following MR signs were studied and compared to intraoperative findings (the latter were considered the gold standard for CSI detection): presence of normal pituitary gland between the adenoma and CS, status of the CS venous compartments, CS size, CS lateral wall bulging, displacement of the intracavernous internal carotid artery (ICA) by adenoma, grade of parasellar extension (Knosp-Steiner classification) and percentage of intracavernous ICA encased by the tumor. Statistical analysis was performed using qui-square testing and sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were obtained for each MR finding. The following signs have been found to represent accurate criteria for non-invasion of the CS: 1- normal pituitary gland interposed between the adenoma and the CS (PPV, 100%); 2- intact medial venous compartment (PPV, 100%); 3- percentage of encasement of the intracavernous ICA lower than 25% (NPV, 100%) and 4- medial intercarotid line not crossed by the tumor (NPV, 100%). Criteria for CSI were: 1- percentage of encasement of the intracavernous ICA higher than 45%; 2- occlusion of three or more CS venous compartments and 3- occlusion of the CS lateral venous compartment. The CS was very likely to be invaded if the inferior venous compartment was not detected (PPV. 92,8%), if the lateral intercarotid line was crossed (PPV. 96,1%) or if a bulging lateral dural wall of the CS was seen (PPV, 92,3%). The preoperative diagnosis of CSI by PA is extremely important since endocrinological remission is rarely obtained after microsurgery alone in patients with invasive tumors. The above mentioned MR imaging criteria may be useful in advising most of the patients preoperatively on the potential need for complimentary therapy after surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15273840     DOI: 10.1590/s0004-282x2004000300011

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  6 in total

Review 1.  Cavernous sinus medial wall: dural or fibrous layer? Systematic review of the literature.

Authors:  Mariangela Barbi Gonçalves; Jean Gonçalves de Oliveira; Hillary Ann Williams; Regina Maria Papais Alvarenga; José Alberto Landeiro
Journal:  Neurosurg Rev       Date:  2011-10-19       Impact factor: 3.042

2.  Radiological features for the approach in trans-sphenoidal pituitary surgery.

Authors:  Victoria Twigg; Simon D Carr; Ramkishan Balakumar; Saurabh Sinha; Showkat Mirza
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

3.  Endosphenoidal coil for intraoperative magnetic resonance imaging of the pituitary gland during transsphenoidal surgery.

Authors:  Prashant Chittiboina; S Lalith Talagala; Hellmut Merkle; Joelle E Sarlls; Blake K Montgomery; Martin G Piazza; Gretchen Scott; Abhik Ray-Chaudhury; Russell R Lonser; Edward H Oldfield; Alan P Koretsky; John A Butman
Journal:  J Neurosurg       Date:  2016-03-18       Impact factor: 5.115

4.  Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.

Authors:  Daizo Yoshida; Akira Teramoto
Journal:  Cell Adh Migr       Date:  2007-01-27       Impact factor: 3.405

5.  Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas.

Authors:  Wang Jia; Runchun Lu; Guijun Jia; Ming Ni; Zhiqing Xu
Journal:  Tumour Biol       Date:  2013-02-13

6.  Quantitative analysis of anatomical relationship between cavernous segment internal carotid artery and pituitary macroadenoma.

Authors:  Bon-Jour Lin; Tzu-Tsao Chung; Meng-Chi Lin; Chin Lin; Dueng-Yuan Hueng; Yuan-Hao Chen; Chung-Ching Hsia; Da-Tong Ju; Hsin-I Ma; Ming-Ying Liu; Chi-Tun Tang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.